SCM
Sio Capital Management Portfolio holdings
AUM
$249M
This Quarter Return
+48.44%
1 Year Return
+117.71%
3 Year Return
+238.99%
5 Year Return
+411.91%
10 Year Return
+912.87%
AUM
$388M
AUM Growth
+$388M
(+20%)
Cap. Flow
+$25.3M
Cap. Flow
% of AUM
6.52%
Top 10 Holdings %
Top 10 Hldgs %
82.04%
Holding
61
New
5
Increased
9
Reduced
7
Closed
18
Top Buys
| 1 |
MRTX
Mirati Therapeutics, Inc. Common Stock
MRTX
|
$85.3M |
| 2 |
GRCL
Gracell Biotechnologies Inc. American Depositary Shares
GRCL
|
$29.3M |
| 3 |
Cigna
CI
|
$17.5M |
| 4 |
IMGN
Immunogen Inc
IMGN
|
$12.2M |
| 5 |
Protagonist Therapeutics
PTGX
|
$4.86M |
Top Sells
| 1 |
GE HealthCare
GEHC
|
$16.5M |
| 2 |
BCYC
Bicycle Therapeutics
BCYC
|
$16M |
| 3 |
Pfizer
PFE
|
$14.9M |
| 4 |
Organon & Co
OGN
|
$13.3M |
| 5 |
Regeneron Pharmaceuticals
REGN
|
$12.6M |
Sector Composition
| 1 | Healthcare | 99.95% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
51
Pfizer
PFE
$141B
| – | – |
-450,700
| Closed | -$14.9M |
|
|
52
Regeneron Pharmaceuticals
REGN
$61.5B
| – | – |
-15,250
| Closed | -$12.6M |
|
53
Repare Therapeutics
RPTX
$71.7M
| – | – |
-76,049
| Closed | -$919K |
|
54
Revolution Medicines
RVMD
$7.1B
| – | – |
-72,700
| Closed | -$2.01M |
|
55
Sight Sciences
SGHT
$213M
| – | – |
-246,699
| Closed | -$831K |
|
56
Sarepta Therapeutics
SRPT
$1.78B
| – | – |
0
| – | – |
|
57
Savara
SVRA
$567M
| – | – |
-896,250
| Closed | -$3.39M |
|
58
Travere Therapeutics
TVTX
$1.56B
| – | – |
-884,770
| Closed | -$7.91M |
|
59
Viking Therapeutics
VKTX
$3.04B
| – | – |
-595,002
| Closed | -$6.59M |
|
|
RVNC
60
DELISTED
Revance Therapeutics, Inc.
RVNC
| – | – |
-342,477
| Closed | -$3.93M |
|
|
KRTX
61
DELISTED
Karuna Therapeutics, Inc. Common Stock
KRTX
| – | – |
-24,129
| Closed | -$4.08M |
|